Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia

PURPOSE: To assess and compare the levels of functioning in patients with major depressive disorder treated with either duloxetine with a daily dose of ≤60 mg or a selective serotonin reuptake inhibitor (SSRI) as monotherapy for up to 6 months in a naturalistic setting in East Asia. In addition, thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Novick, Diego, Montgomery, William, Haro, Josep Maria, Moneta, Maria Victoria, Zhu, Gang, Yue, Li, Hong, Jihyung, Dueñas, Héctor, Brugnoli, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770062/
https://www.ncbi.nlm.nih.gov/pubmed/26966361
http://dx.doi.org/10.2147/NDT.S100675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770062/
https://www.ncbi.nlm.nih.gov/pubmed/26966361
http://dx.doi.org/10.2147/NDT.S100675

Ejemplares similares